• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Laura A. Demopoulos, Rachel Bijou, Icilma V. Fergus, Michael Jones, Joel A. Strom, Thierry H. Lejemtel
  • Medicine
  • Journal of the American College of Cardiology
  • 1997 (First Published: 1 March 1997)
  • OBJECTIVES The aims of the study were to 1) assess the effects of 12 weeks of exercise training at low work loads (i.e., corresponding to < or = 50% of peak oxygen consumption [Vo2]) on peak Vo2 andContinue Reading
  • William H. Frishman, John B. Kostis, +7 authors Edmund H. Sonnenblick
  • Medicine
  • American heart journal
  • 1979 (First Published: 1 October 1979)
  • Abstract Pindolol, a new beta-adrenergic blocking drug with intrinsic sympathomimetic activity, and propranolol were given in increasing equipotent doses (pindolol: 2.5 to 10 mg. every 6 hours;Continue Reading
  • William H. Frishman, Shlomo Charlap, +4 authors Joel A. Strom
  • Medicine
  • Circulation
  • 1988 (First Published: 1 April 1988)
  • The efficacy and safety of oral nifedipine and diltiazem were compared in 20 patients with stable angina pectoris with use of a placebo run-in, randomized, double-blind titration to maximal effectContinue Reading
  • William H. Frishman, Thomas D. Giles, +7 authors Joel A. Strom
  • Medicine
  • Journal of clinical pharmacology
  • 1989 (First Published: 1 December 1989)
  • The safety and efficacy of using continuous high-dose transcutaneous nitroglycerin in doses up to 100 mg/24 hours in chronic stable angina was assessed in 20 patients using serial treadmill testing.Continue Reading
  • William H. Frishman, R Davis, +5 authors Edmund H. Sonnenblick
  • Medicine
  • American heart journal
  • 1979 (First Published: 1 September 1979)
  • Abstract Pindolol (LB-46) is a new beta-adrenoceptor blocking agent with intrinsic sympathomimetic activity. In order to evaluate the efficacy of pindolol in the treatment of patients withContinue Reading